Can the laboratory assay of protein C activity assist in monitoring the hemostatic function in pre-eclampsia?

Blood Coagulation and Fibrinolysis

Volumn 10, Issue 3, 1999, Pages 127-132

  He, S ^a   Bremme, Katarina ^a,b   Blomback M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Latent disseminated intravascular coagulation; Liver function; Pre eclampsia; Protein C activity

Indexed keywords

ANTICOAGULANT AGENT; D DIMER; FIBRIN; PROTEIN C; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; ANTICOAGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRIN FORMATION; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; LABORATORY TEST; PATIENT MONITORING; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; REVIEW; THROMBIN TIME;

EID: 0032946708     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199904000-00003     Document Type: Review

References (30)

1. Dahlbäck B, Stenflo J. A natural anticoagulant pathway: protein C, SC4b-binding protein and thrombo-modulin. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD (editors): Haemostasis and thrombosis. Edinburgh: Churchill Livingstone; 1994. pp. 671-698.
2. Dahlbäck B, Stenflo J. The protein C anticoagulant system. In: Stamatoyannopoulos G, Majerus PW, Varmus H (editors): The molecular basis of blood disease. Philadelphia: W.B. Saunders; 1994. pp. 599- 627.
3. Krishnamurti C, Young GD, Barr CF, Colleton CA, Alving BM. Enhancement of tissue plasminogen activator-induced fibrinolysis by activated protein C in endotoxin-treated rabbits. J Lab Clin Med 1991; 118: 523-530.
4. de Fouw NJ, de Jong YF, Haverkate F, Bertina RM. Activated protein C increases fibrin clot lysis by neutralization of plasminogen activator inhibitor - no evidence for a cofactor role of protein S. Thromb Haemost 1988; 60: 328-333.
5. Giles AR. Disseminated intravascular coagulation. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD (editors): Haemostasis and thrombosis. Edinburgh: Churchill Livingstone; 1994. pp. 969-986.
6. Hesselvik JF, Malm J, Dahlbäck B, Blombäck M. Protein C, protein S and C4b-binding protein in severe infection and septic shock. Thromb Haemost 1991; 65: 126-129.
7. Castelino DJ, Salem HH. Natural anticoagulants and the liver. J Gastroenterol Hepatol 1997; 12: 77-83.
8. Bell H, Odegaard OR, Andcrsson T, Raknerud N. Protein C in patients with alcoholic cirrhosis and other liver diseases. J Hepatol 1992; 14: 163-167.
9. Greer IA. Pathological processes in pregnancy-induced hypertension and intrauterine growth retardation: 'an excess of heated blood'. In: Greer IA, Turpie AGG, Forbes CD (editors): Haemostasis and thrombosis in obstetrics and gynecology. London: Chapman & Hall Medical; 1992. pp. 163-202.
10. He S, Bremme K, Blombäck M. Acquired deficiency of antithrombin in association with a hypercoagulable state and impaired function of liver and/or kidney in pre-eclampsia. Blood Coag Fibrinol 1997; 8: 232-238.
11. He S, Bremme K, Blombäck M. Relative reductions in plasma levels of fibrin D-dimer as predictors for birth of neonates with small-for-gestational-age in pre-eclampsia. Hypertension in Pregnancy 1998; 17: 217- 226.
12. Paternoster DM, Stella A, Simioni P, Mussap M, Plebani M. Coagulation and plasma fibronectin parameters in HELLP syndrome. Int J Gynaecol Obstet 1995; 50: 263-268.
13. de Boer K, Büller HR, ten Gate JW, Treffers PE. Coagulation studies in the syndrome of haemolysis, elevated liver enzymes and low platelets. Br J Obstet Gynaecol 1991; 98:42-47.
14. de Boer K, ten Gate W, Sturk A, Borm JJJ, Treffers PE. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol 1990; 97: 506-510.
15. Paternoster D, Stella A, Similoni P, Trovo P, Girolami A. Clotting inhibitors and fibronectin as potential markers in preeclampsia. Int J Gynecol Obstet 1994; 47:215-221.
16. Terao T, Maki M, Ikenoue T, Gotoh K, Murata M, Iwasaki H, et al. The relationship between clinical signs and hypercoagulable state in toxemia of pregnancy. Gynecol Obstet Invest 1991; 31: 74-85.
17. Espana F, Estellès A, Aznar J, Gilabert J. Assay of protein C in human plasma: comparison of amidolytic, coagulation and immunochemical assays. Thromb Res 1986; 44: 771-782.
18. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. J Am Obstet Gynecol 1988; 158: 892-898.
19. Blombäck M, Eneroth P, Landgren BM, Lagerström M, Anderson O. On the intraindividual and gender variability of haemostatic components. Thromb Haemost 1992; 67: 70-75.
20. Ødegaard OR, Try K, Andersson TR. Protein C: an automated activity assay. Haemostasis 1987; 17:109-113.
21. Abildgaard U, Lie M, Ødegaard OR. Antithrombin heparin co-factor assay with new chromogenic substrates S-2238 and Chromozym TH. Thromb Res 1977; 11: 549-553.
22. Wiman B, Rånby M. Determination of soluble fibrin in plasma by a rapid and quantitative spectrophotometric assay. Thromb Haemost 1986; 55: 189-193.
23. Pelzer H, Schwanz A, Heimbürger N. Determination of human thrombin antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 1988; 59: 101-106.
24. Elms MJ, Bunce TH, Bundesen PG, Rylatt DB, Webber AJ, Bunce IH. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies. Thromb Haemost 1983; 50: 591-594.
25. Müller-Berghaus G, Blombäck M, ten Gate JW. Attempts to define disseminated intravascular coagulation. In: Müller-Berghaus G, Blombäck M, ten Gate JW (editors): DIC, pathogenesis, diagnosis and therapy of disseminated intravascular fibrin formation, Amsterdam: Excerpta Medica; 1993. pp. 3-8.
26. Riess H, Himmelreich G, Jochum M, Machleidt W, Hunt K, Neuhaus P, et al. Hemostasis in orthotopic liver transplantation - a model for study DIC development? In: Müller-Berghaus G, Blombäck M, ten Gate JW (editors): DIC, pathogenesis, diagnosis and therapy of disseminated intravascular fibrin formation. Amsterdam: Excerpta Medica; 1993. pp. 71- 78.
27. Esmon CT. Regulation of protein C activation by components of the endothelial cell surface. In: Gimbrone MA (editor): Vascular endothelium in hemostasis and thrombosis. London: Churchill Livingstone; 1986. pp. 99-118.
28. Esmon CT, Esmon NL. Protein C activation. Semin Thromb Hemost 1984; 10: 122-130.
29. Gunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap LC. Common complications of pregnancy. In: Gunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap LC (editors): Willams obstetrics. Norwalk: Appleton & Lange; 1993. pp. 783-816.
30. Moss DW, Henderson AR, Kachmar JF. Enzymes. In: Tietz NW (editor): Fundamentals of clinical chemistry. London: W.B, Saunders; 1987. pp. 347-417.